Baird lowered the firm’s price target on Agilon Health (AGL) to $1 from $5 and keeps a Neutral rating on the shares. The firm adjusted the price target after updating its power rankings in managed care and healthcare facilities.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AGL:
- Agilon Health’s Earnings Call: Challenges and Optimism
- Agilon Health Faces Uncertainty Amid RAF Challenges and Leadership Changes
- Agilon Health price target lowered to $1.50 from $4 at Benchmark
- Agilon Health price target lowered to $1 from $4 at TD Cowen
- Agilon Health Reports Q2 2025 Results Amid Leadership Change